Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2012
10/25/2012US20120270887 Method Of Inhibiting Myopia And Application Of An Adenylyl Cyclase Inhibitor As A Drug For inhibiting Myopia
10/25/2012US20120270881 Conformationally constrained, fully synthetic macrocyclic compounds
10/25/2012US20120270874 Biaryl Compositions and Methods for Modulating a Kinase Cascade
10/25/2012US20120270869 Pyridyl derivatives as cftr modulators
10/25/2012US20120270868 Rho kinase inhibitors
10/25/2012US20120270862 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/25/2012US20120270855 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
10/25/2012US20120270850 Metal delivery agents and therapeutic uses of the same
10/25/2012US20120270845 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
10/25/2012US20120270805 Cyclosporin compositions
10/25/2012US20120270804 Methods for the treatment and prevention of ocular disorders
10/25/2012US20120270770 Anti-angiogenic peptides and their uses
10/25/2012US20120270265 Methods of obtaining a specific binding member that binds eotaxin
10/25/2012US20120269903 Novel mannopyranoside derivatives with anticancer activity
10/25/2012US20120269894 Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration
10/25/2012US20120269880 Purified amniotic membrane compositions and methods of use
10/25/2012US20120269867 Methods of treating central nervous system tumors
10/25/2012US20120269865 Nutritional composition for promoting gut microbiota balance and health
10/25/2012US20120269862 Ophthalmic composition with a viscosity enhancement system having two different viscosity enhancing agents
10/25/2012US20120269845 Opthalmic composition containing xanthan gum and amino acid
10/25/2012US20120269836 Vaccine
10/25/2012US20120269831 Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
10/25/2012US20120269816 Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor-I
10/25/2012US20120269785 Systemic, allogenic stem cell therapies for treatment of diseases in canines
10/25/2012US20120269772 Lipid depot formulations
10/25/2012US20120269760 Eye Drops
10/24/2012EP2514747A1 Substituted aminothiazine derivative
10/24/2012EP2514423A2 Method of treatment of age-related macular degeneration (AMD)
10/24/2012EP2514420A2 Use of rapamycin for the treatment or prevention of age-related macular degeneration
10/24/2012EP2513072A1 Pyrazine derivatives,process for manufacture and use thereof
10/24/2012EP2512515A1 Pharmaceutical composition for treatment of dry eye syndrome
10/24/2012EP2512492A1 Methods of inhibiting cataracts and presbyopia
10/24/2012EP2512230A1 Non-irritating ophthalmic povidone-iodine compositions
10/24/2012CN102753165A Composition including naphthoquinone compound for treating and preventing hearing loss
10/24/2012CN102753163A Composition comprising as active ingredient l-carnitine in combination with hydroxykynurenine-o-beta-dl-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
10/24/2012CN102746301A 8-phenyl-7,8-dihydropyrido[2,3-d]pyrimidin-7-ones and their use as pharmaceuticals
10/24/2012CN102746300A 8-phenyl-7,8-dihydropyridines[2,3-d]pyrimidine-7-ketone and uses as medicament
10/24/2012CN102746299A 8-PHENYL-7,8-DIHYDROPYRIDO[2,3-d]PYRIMIDIN-7-ONES AND THEIR USE AS PHARMACEUTICALS
10/24/2012CN102744136A Preparation method for nanometre pearl powder
10/24/2012CN102743767A Rnai-mediated inhibition of gremlin for treatment of iop-related conditions
10/24/2012CN102743764A Application of RNA interference target sequence of RhoA in preparation of drugs for treatment of glaucoma
10/24/2012CN102743763A Drug for treating glaucoma
10/24/2012CN102743760A Bacteriostatic agent GellanGum-containing externally-used composite for eyes
10/24/2012CN102743647A Chinese patent medicine granules for treating vitreous opacity
10/24/2012CN102743598A var. Denneanum extract and formula particles thereof
10/24/2012CN102743576A Traditional Chinese medicine preparation for treating tinnitus and deafness
10/24/2012CN102743575A Medicinal liquor
10/24/2012CN102743560A Ear drop medicament for treating chronic suppurative otitis media
10/24/2012CN102743502A Traditional Chinese medicine for relieving vision fatigue
10/24/2012CN102743500A Chinese medicine for treating otogenic Menierss syndrome
10/24/2012CN102743490A Chinese medicament for treating acute otitis media
10/24/2012CN102743452A Myopia prevention beverage
10/24/2012CN102743413A Preparation method of eye drops for alleviating asthenopia
10/24/2012CN102743391A Methylprednisolone or its derivative-containing externally-used composite for eyes
10/24/2012CN102743385A Modulators of atp-binding cassette-transporters
10/24/2012CN102743371A Medicine for treating retinal neovascular diseases
10/24/2012CN102743368A Compounds for the treatment of metabolic disorders
10/24/2012CN102743340A Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate
10/24/2012CN102743335A Timolol hydrogenmaleate eye drops and preparation method thereof
10/24/2012CN102389392B Recombinant bovine basic fibroblast growth factor gel for eye use
10/24/2012CN102210821B Traditional Chinese medicine for treating xerophthalmia
10/24/2012CN101854939B 眼科用组合物 Ophthalmic composition
10/23/2012US8293755 Treatment of statin side effects using uridine derivatives
10/23/2012US8293742 Preferential vasoconstriction compositions and methods of use
10/23/2012US8293713 Beta-turn peptidomimetic cyclic compounds for treating dry eye
10/23/2012US8293223 Treatment of organ injuries and burns using placental stem cells
10/23/2012US8293210 Extruding mixture of alpha-2 adrenergic receptor agonist (brimonidine) and biodegradable polylactide
10/23/2012CA2699599C Pharmacological adjunctive treatment associated with glaucoma filtration surgery
10/23/2012CA2527703C New use of staurosporine derivatives
10/23/2012CA2508303C Drug delivery system using subconjunctival depot
10/23/2012CA2441410C Compounds and method of treatment having agonist-like activity selective at alpha 2b or 2b/2c adrenergic receptors
10/18/2012WO2012142372A2 Compositions and methods for the treatment of nasal conditions
10/18/2012WO2012141334A1 Aqueous ophthalmic composition
10/18/2012WO2012140636A1 A probiotic formulation
10/18/2012WO2012139164A1 Polymer conjugated prostaglandin analogues
10/18/2012WO2012122334A3 Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
10/18/2012WO2012099448A3 RECOMBINANT ADENOVIRUS EXPRESSING αA-CRYSTALLIN GENE AND GENE THERAPY FOR RETINAL VASCULAR DISEASE USING SAME
10/18/2012US20120264798 Prodrugs of inhibitors of plasma kallikrein
10/18/2012US20120264790 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
10/18/2012US20120264769 Methanocarba adenosine derivatives and dendrimer conjugates thereof
10/18/2012US20120264768 Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
10/18/2012US20120264759 Benzyl substituted triazine derivatives and their therapeutical applications
10/18/2012US20120264740 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
10/18/2012US20120264732 Phenyl bicyclic methyl azetidine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264730 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264729 Co-crystals and salts of ccr3-inhibitors
10/18/2012US20120264716 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264715 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264708 Method For Treatment Of Macular Degeneration By Modulating P2Y12 or P2X7 Receptors
10/18/2012US20120264693 Compounds acting as peptide gap junction modulators, and uses thereof
10/18/2012US20120264689 Methods and compositions for skin regeneration
10/18/2012US20120264681 Buffered ophthalmic compositions and methods of use thereof
10/18/2012US20120264676 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
10/18/2012US20120263809 Nutritional Supplement Comprising Nut and Seed Oil Composition
10/18/2012US20120263803 Aqueous ophthalmic composition
10/18/2012US20120263794 Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor
10/18/2012US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/18/2012US20120263786 Pharmaceutical Formulations Containing an SGLT2 Inhibitor
10/18/2012US20120263779 Biodegradable drug delivery system
10/18/2012US20120263747 Albumin-Fused Anti-Angiogenesis Peptides
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 531